← Home / INSMED INCORPORATED (INSM)
Stock Analysis
INSMED INCORPORATED (INSM)
INSM
INSM · Market data
131.11 -1.09%
Track INSM in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when INSM price is:
52W Range Position
33%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-08 20:06 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 146.30. Holding above 127.01 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
127.01
↗
Break Above
Confirmation improves above resistance.
146.30
🎯
Next Objective
Pattern-derived target if setup continues.
142.66
×
Thesis Break
Scenario weakens below invalidation.
Below 127.01
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
6
●
Financial Results
HIGH
INSM reports financial results
On August 6, 2026, Insmed Incorporated (the “Company”) issued a press release regarding its financial results for the second quarter ended June 30, 2026.
8-K Filing • SEC EDGAR
MAY
7
●
Financial Results
HIGH
Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today reported financial results for the first quarter ended March 31, 2026, and provided a business update.
8-K Filing • SEC EDGAR
What's Driving INSM?
📈 Technical recovery is improving
Momentum is Neutral. Watch 146.30 for confirmation and 127.01 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 127.01
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend breakout active · 1 bars old · score 100
Trigger
118.52
First Resistance
119.54
Target
142.66
Invalidation
115.50
DT Break
fresh (age 1)
Price Chart
INSM — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-07
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$28.4B
Company size
EV
$28.6B
Debt-adjusted value
P/E
-24.0
Not meaningful
P/S
34.6
Very high
P/B
40.3
Very high
EV/Sales
34.9
Very high
EV/EBIT
-24.8
Not meaningful
P/FCF
-30.8
Not meaningful
FCF Yield
-3.25%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Manageable
💵 Revenue
305.96M
↗ Strong
📈 Net Income
-163.56M
↘ Negative
🧮 EPS (Basic)
-0.76
↘ Negative
INSMED INCORPORATED
Related Opportunities